Biotechnology company Novavax announced the appointment of Mark Casey as chief legal officer and corporate secretary, effective Dec. 11.

Casey most recently served as chief legal officer and corporate secretary at Bryn Pharma.

He previously served as chief legal officer, corporate secretary, and executive chairman of the board - specialty generics at Mallinckrodt Pharmaceuticals. Earlier, he held executive leadership roles at Idera Pharmaceuticals and Hologic.